Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
51.1M
-
Number of holders
-
174
-
Total 13F shares, excl. options
-
29.8M
-
Shares change
-
+1.39M
-
Total reported value, excl. options
-
$1.25B
-
Value change
-
+$33.8M
-
Put/Call ratio
-
0.9
-
Number of buys
-
102
-
Number of sells
-
-86
-
Price
-
$41.95
Significant Holders of REGENXBIO Inc. - Common Stock, par value $0.0001 per share (RGNX) as of Q4 2018
227 filings reported holding RGNX - REGENXBIO Inc. - Common Stock, par value $0.0001 per share as of Q4 2018.
REGENXBIO Inc. - Common Stock, par value $0.0001 per share (RGNX) has 174 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29.8M shares
of 51.1M outstanding shares and own 58.37% of the company stock.
Largest 10 shareholders include BlackRock Inc. (4.82M shares), Vanguard Group Inc (3.39M shares), STATE STREET CORP (1.97M shares), Redmile Group, LLC (1.35M shares), JPMORGAN CHASE & CO (1.1M shares), RTW INVESTMENTS, LP (1.05M shares), WS MANAGEMENT LLLP (1.02M shares), FMR LLC (941K shares), RENAISSANCE TECHNOLOGIES LLC (885K shares), and WELLINGTON MANAGEMENT GROUP LLP (661K shares).
This table shows the top 174 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.